Canada Markets closed

Windtree Therapeutics, Inc. (WINT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3100-0.1100 (-7.75%)
At close: 04:00PM EST
1.3100 0.00 (0.00%)
After hours: 06:03PM EST
Sign in to post a message.
  • J
    Ist quarter 2022 I hope good news
  • s
    There has been massive buying pre market in a number of occasions lately. Someone is buying massive loads of shares going into the new year so something is definitely happening
  • A
    i have %50 percent of my portfolio in windtree, i believe in this shares stocks they have great future in 2022 and long time too

    just waiting holding,holding you did put money here is because you believe in the project
  • s
    =18% ah so this could be good
  • J
    I bought more today.
  • M
    I am with you Anthony in that I am optimistic regarding the potential of WINT's pipeline and believe that they are addressing an important population in a high value market. Lots of upside potential!
  • M
    WINT will have it's moment, but it will take time and patients is required. I am in for the long haul.
  • s
    New patent 😀
  • F
    Are we hoping for New Year Updates!!!
  • A
    Top Bullish Charts | June 2021 💰💵📈
  • H
    Can anyone explain to me why this company can get financing above the current stock price by so much, yet the stock price still not moving up much?
  • R
    Just bought today at 2.76$ I'm going to hold till 8.00$ in 6 months.
  • C
    Data of their Lucinactant (KL4 Surfactant) will be out July-August. This is to treat lung injury due to covid-19, and it’s promising so far. This should skyrocket once positive data is out!
  • j
    Very possible surfactant just might come out in assisting Covid 19 patients during or even after the virus hits. Afterwards many of these patients are experiencing lung scarring
  • J
    Check out insider purchases the last couple of weeks.
  • s
    October 12, 2021 7:30 AM EDT
    Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results from its Istaroxime ECS Study
  • I
    Over 10% of 26 million share float is short. This morning are BUYS,not short covering,that will begin at the open.

    Could be interesting with such a small market cap,
  • D
    public offer soon
  • D
    As a Respiratory Therapist, WINT is very exciting. However, I’ve been following and analyzing for years and have come to the conclusion that there are lots of strings being pulled, none in favor of the investor.
  • a
    I think will be 3.5 -4.5 $
    Monday as VTNR when up target to 25 $

    and I hope so that